All you need to get started with ETF selection and analysis. Create your account now →

Help us improve your experience. Please confirm your investor type:

ETF What's Up

Don’t Miss a Move in the ETF Market

Sign up and keep track of everything that moved the ETF industry this week. From new launches to regulatory shifts across the Atlantic.

ETF What's Up

You may unsubscribe at any time by clicking the “unsubscribe” link within the emailed newsletter. By signing up, you agree to our Privacy Policy and Terms and Conditions.

WHEA

State Street SPDR MSCI World Health Care UCITS ETF

The WHEA Exchange Traded Fund (ETF) is provided by State Street Investment Management. It is built to track an index: MSCI World Health Care Capped 35/20 Index. The WHEA ETF provides physical exposure, so by buying it you actually own parts of all the 113 underlying holdings. The dividend policy is capitalization.

Advertisement

API
PerformanceDec 31, 2025 - Jul 17, 2026
-6%-4%-2%0%2%4%6%JANMARMAYJUL
Flows
Join for free to unlock
Data as of 05/31/26
Healthcare
97.53%
Consumer Non-Cyclicals
1.50%
Other
0.90%
Latest WHEA news

No content available for this fund

FAQ about WHEA

WHEA is a Passive ETF. This ETF provides exposure to Large and Mid-Cap Developed markets Health Care Equities.
WHEA tracks the MSCI World Health Care Capped 35/20 NTR Index - USD, through a full replication replication method.
WHEA carries a total expense ratio (TER) of 0.3%, indicating the annual cost for holding the fund.
WHEA was introduced to the market on April 29, 2016. It trades on Austria, among other exchanges
State Street SPDR MSCI World Health Care UCITS ETF, WHEA, is provided by State Street Investment Management. Learn more about State Street Investment Management here.
WHEA oversees €578M in assets as of July 17, 2026.
WHEA follows a capitalizing, meaning it reinvests income within the fund.
As of May 31, 2026, WHEA has significant geographic allocations in USA, Switzerland and United Kingdom.
As of May 31, 2026, WHEA focuses largely on Healthcare and Consumer Non-Cyclicals.
As of May 31, 2026, WHEA holds 113 positions in its portfolio, with 57.47% of assets concentrated in its top 15 holdings.
As of May 31, 2026, WHEA top three holdings include Eli Lilly & Co., Johnson & Johnson and AbbVie, Inc..
The base currency of WHEA is USD.
Data as of 05/31/26
Eli Lilly & Co.
11.50%
Johnson & Johnson
7.03%
AbbVie, Inc.
4.99%
UnitedHealth Group, Inc.
4.48%
Roche Holding AG
3.84%
Merck & Co., Inc.
3.80%
AstraZeneca PLC
3.64%
Novartis AG
3.57%
Thermo Fisher Scientific, Inc.
2.37%
Amgen, Inc.
2.35%

Trackinsight
Essentials

A forever free toolbox for fund selection, analysis, research, and ETF portfolio construction.

Essential free account includes:
  • More fund data
  • Compare up to 3 funds
  • More screener filters
  • Edit screener columns from 100+ metrics
  • Watchlists for saving your research
  • Portfolio construction and analysis
  • Personal dashboard for live monitoring

Advertisement

Trackinsight

About Trackinsight

Since our founding in 2016, we have been at the forefront of the industry, delivering accessible, comprehensive, and reliable tools to support the evolving needs of investors.

Over the past decade, Trackinsight has expanded its operations across six countries, serving thousands of professional investors. We’ve consistently innovated to provide cutting-edge solutions that meet the changing demands of the ETF market.

In 2024, Kepler Cheuvreux, a leading independent European financial services firm, acquired a majority stake in Trackinsight, becoming the company's principal shareholder.

This strategic partnership solidifies Trackinsight's position as a premier provider of ETF selection and analysis tools, while strengthening Kepler Cheuvreux’s commitment to becoming a leading player in the ETF sector.

Together, we are committed to offering advanced services that empower professional investors, advisors, institutions, and issuers. This new step enables us to deliver even more comprehensive and innovative technological solutions, driving ETF investing to new heights.

More about Trackinsight
© 2014-2026 Trackinsight SA. All rights reserved.
Privacy policy  |  Cookie policy  |    |  Terms of use  |  Imprint
Trackinsight